Published in Cell Mol Biol on January 01, 1987
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (1984) 10.38
Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science (1992) 5.25
Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med (1999) 4.79
Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science (1984) 4.02
Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol (2005) 3.84
Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science (1997) 3.68
Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry (2002) 3.41
Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet (1985) 3.27
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci U S A (1991) 3.22
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology (2006) 2.90
Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol (1993) 2.71
Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol (1987) 2.62
Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke (2000) 2.59
Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet (1984) 2.56
False-negative diffusion-weighted MR findings in acute ischemic stroke. AJNR Am J Neuroradiol (2000) 2.42
Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet (1984) 2.32
BSE transmission to macaques. Nature (1996) 2.32
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg (2000) 2.25
Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology (1985) 2.23
Molecular cloning of lymphadenopathy-associated virus. Nature (1985) 2.22
Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet (1984) 2.19
env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J Virol (2000) 2.17
The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J (2001) 2.16
Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J (2001) 2.10
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry (2005) 2.08
Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT. Bone Marrow Transplant (2002) 2.06
Human immunodeficiency virus type-1: mother-to-child transmission. Meeting of World Federation of Scientists in Erice, Italy, August 2000. Joint report of AIDS/Infectious Diseases PMP and Mother and Child PMP. Acta Paediatr (2000) 2.02
Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet (2004) 2.02
Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. J Virol (1997) 2.00
Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome. Science (1984) 1.97
Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science (1984) 1.95
High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol (2000) 1.94
Diffusion-weighted MRI in acute stroke within the first 6 hours: 1.5 or 3.0 Tesla? Neurology (2010) 1.94
Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochem Biophys Res Commun (1984) 1.94
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA (1996) 1.94
Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene (1989) 1.83
Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am J Physiol Renal Physiol (2000) 1.77
Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science (1984) 1.73
Are the brains of monozygotic twins similar? A three-dimensional MR study. AJNR Am J Neuroradiol (1998) 1.71
Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science (1992) 1.71
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (1985) 1.70
Pallidal stimulation for Parkinson's disease. Two targets? Neurology (1997) 1.69
MR determination of hippocampal volume: comparison of three methods. AJNR Am J Neuroradiol (1996) 1.66
Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease. Lancet (1994) 1.61
Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry (2005) 1.60
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease. Bone Marrow Transplant (2005) 1.56
Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD. Neurology (2000) 1.55
Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes. Lancet (1984) 1.51
Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. N Engl J Med (1984) 1.51
Developmental abnormalities of the medial temporal lobe in patients with temporal lobe epilepsy. AJNR Am J Neuroradiol (1995) 1.49
Reliability of the ECASS radiological classification of postthrombolysis brain haemorrhage: a comparison of CT and three MRI sequences. Cerebrovasc Dis (2010) 1.46
Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health. Proc Natl Acad Sci U S A (2001) 1.46
Primary structure and functional organization of Drosophila 1731 retrotransposon. Nucleic Acids Res (1988) 1.45
Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar. Neurology (2002) 1.43
Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol (1991) 1.42
Oestrogen receptors in chick oviduct. Characterization and subcellular distribution. Eur J Biochem (1975) 1.42
Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J Pathol (2000) 1.40
Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages. Virology (1992) 1.39
Phylogenetic analysis of SIV and STLV type I in mandrills (Mandrillus sphinx): indications that intracolony transmissions are predominantly the result of male-to-male aggressive contacts. AIDS Res Hum Retroviruses (1998) 1.39
Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses. Exp Cell Res (2000) 1.38
Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain (2002) 1.38
The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J Biol Chem (2001) 1.38
Pathogenesis of the oral route of infection of mice with scrapie and bovine spongiform encephalopathy agents. J Gen Virol (1999) 1.38
[Study of HIV localization in sperm]. Contracept Fertil Sex (1997) 1.37
Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure. Virology (2002) 1.34
Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem (1990) 1.33
Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress. J Immunol (2000) 1.33
Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. Bone Marrow Transplant (2003) 1.32
Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus (2008) 1.32
Intracranial extra-axial cavernous (HEM) angiomas: tumors or vascular malformations? J Neuroradiol (2002) 1.29
The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins. FEBS Lett (1993) 1.27
Aggressive behavior induced by intraoperative stimulation in the triangle of Sano. Neurology (2002) 1.27
Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. Proc Natl Acad Sci U S A (1991) 1.27
A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. J Immunol (1986) 1.25
MR Imaging of the cervical cord in juvenile amyotrophy of distal upper extremity. AJNR Am J Neuroradiol (1989) 1.24
New insight into abnormal prion protein using monoclonal antibodies. Biochem Biophys Res Commun (1999) 1.23
Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts. J Biol Chem (1998) 1.23
Variation of Ap4A and other dinucleoside polyphosphates in stressed Drosophila cells. J Biol Chem (1985) 1.23
Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology (1996) 1.21
Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis. N Engl J Med (1985) 1.21
Characterization of the nuclear import pathway for HIV-1 integrase. J Biol Chem (2001) 1.20
Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus. AIDS Res Hum Retroviruses (1992) 1.19
Combined chemoimmunostimulation therapy against murine leukemia. Cancer Res (1972) 1.18
Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology (2000) 1.16
Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. J Gen Virol (1996) 1.16
The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J Mol Biol (2001) 1.16
Diffusion-weighted imaging patterns of brain damage associated with cerebral venous thrombosis. AJNR Am J Neuroradiol (2001) 1.16
Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol (2000) 1.15
The Drosophila wing differentiation factor vestigial-scalloped is required for cell proliferation and cell survival at the dorso-ventral boundary of the wing imaginal disc. Cell Death Differ (2004) 1.14